Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases

Reviews of Infectious Diseases

Volumn 12, Issue 6, 1990, Pages 1147-1201

  Denning, David W ^a   Stevens, David A ^b  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE; ITRACONAZOLE;

ASPERGILLOSIS; ASPERGILLUS; DRUG EFFICACY; FEMALE; HEART VALVE REPLACEMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RELAPSE; REVIEW; VITRECTOMY;

AMPHOTERICIN B; ANIMAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS; DISEASE MODELS, ANIMAL; FLUCYTOSINE; HUMAN;

EID: 0025241257     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/12.6.1147     Document Type: Article

References (301)

1. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. The spectrum of the disease in 98 patients. Medicine 1970;49:147–73
2. Pennington JE. Aspergillus pneumonia in hematologic malignancy. Improvements in diagnosis and therapy. Arch Intern Med 1977;137:769–71
3. Aisner J, Schimpff SC, Wiernik PH. Tueatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 1977;86:539–43
4. Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS. Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg 1983;198:622–9
5. Britt RH, Enzmann DR, Remington JS. Intracranial infection in cardiac transplant recipients. Ann Neurol 1981; 9:107–19
6. Fisher BD, Armstrong D, Yu B, Gold J.W.M. Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med 1981;71:571–7
7. Gross MH, Pickard WW, Perfect JR. Retrospective review of amphotericin B use in a tertiary-care medical center. Am J Hosp Pharm 1987;44:1353–7
8. Burch PA, Karp JE, Merz WG, Kuhlman JE, Fishman EK. Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol 1987;5:1985–93
9. Alio MD, Miller J, Tbwnsend T, Tan C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med 1987;317:1105–8
10. Graybill JR, Raster SR. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene an- tifungal drug, SCH281911’3. Am Rev Respir Dis 1984; 129:292–5
11. Graybill JR, Ahrens J. Itraconazole treatment of murine aspergillosis. J Med Vet Mycol 1985;23:219–23
12. Arroyo J, Medoff G, Kobayashi GS. Therapy of murine aspergillosis with amphotericin B in combination with rifampin or 5 fluorocytosine. Antimicrob Agents Che- mother 1977;11:21–5
13. Polak A. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Chemotherapy 1987;33:381–95
14. Polak A, Scholer HJ, Wall M. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. Chemotherapy 1982;28:461–79
15. Van Cutsem J, Janssen P.A.J. In-vitro and in-vivo models to study the activity of antifungals against aspergillus. In: Vanden Bossche H, Mackenzie DWR, Cauwenbergh G, eds. Aspergillus and aspergillosis. New York: Plenum Press, 1988:215–27
16. Spreadbury CL, Cohen J. Invasive aspergillosis: clinical and pathological description of a new animal model, and a comparison of the therapeutic efficacy of amphotericin B and fluconazole [abstract]. In: Aspergillus and aspergillosis. Antwerp, Belgium: Janssen Pharmaceutica, 1987:56–7
17. Patterson TF, Miniter P, Ryan JL, Andriole VT. Effect of immunosuppression and amphotericin B on aspergillus antigenemia in an experimental model. J Infect Dis 1988;158:415–22
18. Schaffner A, Frick PG. The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. J Infect Dis 1985;151:902–10
19. Longman LP, Martin MV. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit. J Antimicrob Chemother 1987;20:719–24
20. Carrizosa J, Kohn C, Levison ME. Experimental aspergillus endocarditis in rabbits. J Lab Clin Med 1975;86:746–53
21. Daneshmend TK, Warnock DW. Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet 1983;8:17–42
22. Atkinson AJ Jr, Bennett JE. Amphotericin B pharmacokinetics in humans. Antimicrob Agents Chemother 1978; 13:271–6
23. Drutz DJ, Spickard A, Rogers DE, Koenig MG. TVeatment of disseminated mycotic infections. A new approach to amphotericin B therapy. Am J Med 1968;45:405–18
24. Christiansen KJ, Bernard EM, Gold J.W.M., Armstrong D. Distribution and activity of amphotericin B in humans. J Infect Dis 1985;152:1037–43
25. Rubinstein E, Noriega ER, Simberkoff MS, Rahal JJ Jr. Tissue penetration of amphotericin B in Candida endocarditis. Chest 1974;66:376–7
26. Green WR, Bennett JE, Goos RD. Ocular penetration of amphotericin B. A report of laboratory studies and a case report of postsurgical cephalosporium endophthalmitis. Arch Ophthalmol 1965;73:769–75
27. Emmen F, Storm G. Liposomes in treatment of infectious diseases. Pharm Weekbl [Sci] 1987;9:162–71
28. Bakker-Woudenberg I.A.J.M., Roerdink FH. Antimicrobial chemotherapy directed by liposomes. J Antimicrob Chemother 1986;17:547–52
29. Lopez-Berestein G. Liposomal amphotericin B in the treatment of fungal infections. Ann Intern Med 1986;105:130–1
30. Szoka FC Jr, Milholland D, Barza M. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrob Agents Chemother 1987;31:421–9
31. Lopez-Berestein G. Liposomes as carriers of antimicrobial agents. Antimicrob Agents Chemother 1987;31:675–8
32. Payne NI, Cosgrove RF, Green AP, Liu L. In-vivo studies of amphotericin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue disposition of the drug in mice. J Pharm Pharmacol 1987;39:24–8
33. Barza M, Baum J, Tremblay C, Szoka F, D Amico DJ, Ocular toxicity of intravitreally injected liposomal amphotericin B in rhesus monkeys. Am J Ophthalmol 1985; 100:259–63
34. Scholer HJ. Antimykoticum 5-fluorocytosin. Mykosen 1970;13:179–88
35. Cutler RE, Blair AD, Kelly MR. Flucytosine kinetics in subjects with normal and impaired renal function. Clin Pharmacol Ther 1978;24:333–42
36. Stamm AM, Diasio RB, Dismukes WE, Shadomy S, Cloud GA, Bowles CA, Karam GH, Espinel-Ingroff A. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med 1987;83:236–42
37. Horne MJ, Taylor RF, Williams R, Zylstra W. Candida endophthalmitis. Med J Aust 1975;1:170–2
38. Richards AB, Jones BR, Whitwell J, Clayton YM. Corneal and intra-ocular infection by Candida albicans treated with 5-fluorocytosine. Trans Ophthalmol Soc UK 1969; 89:867–85
39. Schar G, Kayser FH, Dupont MC. Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis. Chemotherapy 1976; 22:211–20
40. Stevens DA. Miconazole in the treatment of systemic fungal infections. Am Rev Respir Dis 1977;116:801–6
41. Komadina TG, Wilkes T.D.I., Shock JP, Ulmer WC, Jackson J, Bradsher RW. TVeatment of Aspergillus fumiga- tus keratitis in rabbits with oral and topical ketocona- zole. Am J Ophthalmol 1985;99:476–9
42. Brass C, Galgiani JN, Blaschke TF, Defelice R, O Reilly RA, Stevens DA, Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother 1982; 21:151–8
43. Sugar AM, Alsip SG, Galgiani JN, Graybill JR, Dismukes WE, Cloud GA, Craven PC, Stevens DA. Pharmacology and toxicity of high-dose ketoconazole. Antimicrob Agents Chemother 1987;31:1874–8
44. Itraconazole investigator’s manual. Beerse, Belgium: Janssen Pharmaceutica, 1987
45. Van Cutsem J, Van Gerven F, Van de Ven M-A, Borgers M, Janssen P.A.J., Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother 1984;26:527–34
46. Hardin TC, Graybill JR, Fetchick R, Woestenborghs R, Rinaldi MG, Kuhn JG. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob Agents Chemother 1988;32:1310–3
47. Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989;86:791–800
48. Hicker RM, Williams PL, Arathoon EG, Stevens DA. Tieatment of mycoses with itraconazole. Ann NY Acad Sci 1988;544:451–70
49. Heykants J, Michiels M, Meuldermans W, Monbaliu J, Lavrijsen K, Van Peer A, Lerron JC, Woestenborghs R, Cauwenbergh G. The pharmacokinetics of itraconazole in animals and man: an overview. In: Fromtling RA, ed. Recent trends in the discovery, development and evaluation of antifungal agents. Barcelona: J. R. Prous Science 1987:223–49
50. Tucker RM, Williams PL, Arathoon EG, Levine BE, Hartstein AI, Hanson LH, Stevens DA. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother 1988;32:369–73
51. Savani DV, Perfect JR, Cobo LM, Durack DT. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother 1987;31:6–10
52. Troke PF, Andrews RJ, Marriott MS, Richardson K. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. J Antimicrob Chemother 1987;19:663–70
53. Stein RS, Greer JP, Ferrin W, Lenox R, Baer MR, Flexner JM. Clinical experience with amphotericin B in acute myelogenous leukemia. South Med J 1986;79:863–70
54. Albelda SM, Talbot GM, Gerson SL, Miller WT, Cassileth PA. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia. Am Rev Respir Dis 1985;131:115–20
55. Capnist G, Chisesi T, Battista R, Dini E. Pulmonary aspergillosis complicating aplastic phase in hematologic patients. Haematologica (Pavia) 1986;71:201–4
56. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 1984;53:411–9
57. Ruutu P, Valtonen V, Elonen E, Volin L, Tlkiainen P, Ruutu T. Invasive pulmonary aspergillosis: a diagnostic and therapeutic problem. Clinical experience with eight haemato- logic patients. Scand J Infect Dis 1987;19:569–75
58. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:345–51
59. Drutz DJ, Spickard A, Koenig MG. New approach to therapy with amphotericin B. Antimicrob Agents Chemother 1966:202–7
60. Denning DW, Williams AH. Invasive pulmonary aspergillosis diagnosed by blood culture and successfully treated. Br J Dis Chest 1987;81:300–4
61. Robertson MJ, Larson RA. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am J Med 1988;84:233–9
62. Karp JE, Burch PA, Merz WG. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med 1988;85:203–6
63. Thcot G, Joosten E, Boogaerts MA, Vande Pitte J, Cauwenbergh G. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev Infect Dis 1987;9(Suppl l):S94–9
64. Mahoney DH Jr, Steuber CP, Starling KA, Barrett FF, Goldberg J, Fembach DJ. An outbreak of aspergillosis in children with acute leukemia. J Pediatr 1979;95:70–2
65. Stein RS, Kayser J, Flexner JM. Clinical value of empirical amphotericin B in patients with acute myelogenous leukemia. Cancer 1982;50:2247–51
66. Borkin MH, Arena FP, Brown AE, Armstrong D. Invasive aspergillosis with massive fatal hemoptysis in patients with neoplastic disease. Chest 1980;78:835–9
67. Daly DB, Doherty A, McCann SR. Successful treatment of invasive pulmonary aspergillosis in a patient with acute leukaemia. Ir J Med Sci 1983;152:103–5
68. Lopez-Berestein G, Fainstein V, Hopfer R, Mehta K, Sullivan MP, Keating M, Rosenblum MG, Mehta R, Luna M, Hersh EM, Reuben J, Juliano RL, Bodey GP. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis 1985;151:704–10
69. Kibbler CC, Milkins SR, Bhamra A, Spiteri MA, Noone P, Prentice HG. Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients. Thorax 1988;43:108–12
70. Shamberger RC, Weinstein HJ, Grier HE, Levey RH. The surgical management of fungal pulmonary infections in children with acute myelogenous leukemia. J Pediatr Surg 1985;20:840–4
71. Walsh TJ, Bulkley BH. Aspergillus pericarditis: clinical and pathologic features in the immunocompromised patient. Cancer 1982;49:48–54
72. Luce JM, Ostenson RC, Springmeyer SC, Hudson LD. In vasive aspergillosis presenting as pericarditis and cardiac tamponade. Chest 1979;76:703–5
73. Jardin M, Remy J. Control of hemoptysis: systemic angiography and anastomoses of the internal mammary artery. Radiology 1988;168:377–83
74. Schubert MM, Peterson DE, Myers JD, Hackman R, Thomas ED. Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature. Cancer 1986;57:1092–6
75. Cordonnier C, Bernaudin J-F, Bierling P, Huet Y, Vernant J-P, Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer 1986;58:1047–54
76. Andersson BS, Luna MA, McCredie KB. Systemic aspergillosis as cause of myocardial infarction. Cancer 1986; 58:2146–50
77. Rotstein C, Cummings KM, Tidings J, Killion K, Powell E, Gustafson TL, Higby D. An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case- control study. Infect Control 1985;6:347–55
78. Pamphilon D, Prentice A, Wedzicha J, Woods M, Matthews R, Burnie J. A clinical and serological study of the effect of itraconazole in the management of invasive aspergillosis. Serodiagnosis and Immunotherapy 1987;1:297–305
79. Sherertz RJ, Belani A, Kramer BS, Elfenbein GJ, Weiner RS, Sullivan ML, Thomas RG, Samsa GP. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 1987;83:709–18
80. Allan BT, Patton D, Ramsey NKC, Day DL. Pulmonary fungal infections after bone marrow transplantation. Pediatr Radiol 1988;18:118–22
81. Wingard JR, Beals SU, Santos GW, Merz WG, Saral R. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 1987;2:175–81
82. Winston DJ, Gale RP, Meyers DV, Young LS, UCLA Bone Marrow Transplantation Group. Infectious complications of human bone marrow transplantation. Medicine 1979;58:1–31
83. Peterson PK, McGlave P, Ramsey NK, Rhame F, Cohen E, Perry GS 3rd, Goldman AL, Kersey J, A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and cytomegalovirus as the major causes of mortality. Infect Control 1983;4:81–9
84. Burton JR, Zachery JB, Bessin R, Rathbun HK, Greenough WB, Sterioff S, Wright JR, Slavin RE, Williams GM. Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B. Ann Intern Med 1972;77:383–8
85. Hooper DC, Pruitt AA, Rubin RH. Central nervous system infection in the chronically immunosuppressed. Medicine 1982;61:166–88
86. Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985;18:574–82
87. Kennedy MS, Deeg HJ, Siegel M, Crowley JJ, Storb R, Thomas ED. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. TVansplantation 1983;35:211–5
88. Viviani MA, Tortorano AM, Woestenborghs R, Cauwenbergh G. Experience with itraconazole in deep mycoses in northern Italy. Mykosen 1987;30:233–44
89. Radovancevic B, Frazier OH, Gentry LO, Okereke O.U.J., Cooley DA. Successful treatment of invasive aspergillosis in a heart transplant patient. Texas Heart Institute Journal 1985;12:233–7
90. Mouy R, Bremard C, Fischer A, H-ong PH, Vilmer E, Griscelli C. Infection aspergillaire et granulomatose sep- tique chronique. Arch Fr Pediatr 1985;42:953–79
91. Simpson J, Kent E, Claassen J, Miller D, Barrett M, Buckley R. Successful treatment of invasive aspergillus infection with itraconazole in chronic granulomatous disease [abstract no. 472]. J Allergy Clin Immunol 1988:81
92. Atkinson GW, Israel HL. 5-Fluorocytosine treatment of meningeal and pulmonary aspergillosis. Am J Med 1973;55:496–504
93. Fields BT Jr, Meredith WR, Galbraith JE, Hardin HF. Studies with amphotericin B and 5-fluorocytosine in aspergillosis. Clin Res 1974;22:32A
94. Dupont B, Drouhet E. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. Rev Infect Dis 1987;9(Suppl 1):S71–6
95. Talbot GH, Weiner MH, Gerson SL, Provencher M, Hurwitz S. Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay. J Infect Dis 1987;155:12–27
96. Albelda SM, Gefter WB, Epstein DM, Miller WT. Bronchopleural fistula complicating invasive pulmonary aspergillosis. Am Rev Respir Dis 1982;126:163–5
97. Ganer A, Arathoon E, Stevens DA. Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole. Rev Infect Dis 1987;9(Suppl 1):S77–86
98. Colp CR, Cook WA. Successful treatment of pleural aspergillosis and bronchopleural fistula. Chest 1975;68:96–8
99. Krakowka P, Rowinska E, Halweg H. Infection of the pleura by Aspergillus fumigatus. Thorax 1970;25:245–53
100. Irani FA, Dolovich J, Newhouse MT. Bronchopulmonary and pleural aspergillosis. Am Rev Respir Dis 1971; 103:552–6
101. Stevens DA, Ganer A, Arathoon E. Clinical experience with azoles in therapy of aspergillus infections. In: Vanden Bossche H, Mackenzie DWR, Cauwenbergh G, eds. Aspergillus and aspergillosis. Beerse, Belgium: Janssen Research Foundation, 1987:133–4
102. Parry MF, Coughlin FR, Zambetti FX. Aspergillus empyema. Chest 1982;81:768–70
103. Kearon MC, Power JT, Wood AE, Clancy LJ. Pleural aspergillosis in a 14 year old boy. Thorax 1987;42:477–8
104. Sawasaki H, Horie K, Yamada M, Tajima G, Katsura S, Naito Y, Watabe S, Murabayashi A, Kukidome S, Jo K, Bronchial stump aspergillosis, experimental and clinical study. J Thorac Cardiovasc Surg 1969;58:198–208
105. Davies SP, Webb WJ, Patou G, Murray WK, Denning DW. Renal aspergilloma-a case illustrating the problems of medical therapy. Nephrology, Dialysis, and Thinsplantation 1987;2:568–72
106. Berlinger NT, Freeman TJ. Acute airway obstruction due to necrotizing tracheobronchial aspergillosis in immunocompromised patients: a new clinical entity. Ann Otol Rhinol Laryngol 1989;718–20
107. Kheir SM, Flint A, Moss JA. Primary aspergillosis of the larynx simulating carcinoma. Hum Pathol 1983;14:184–6
108. Rao PB. Aspergillosis of larynx. J Laryngol Otol 1969; 83:377–9
109. Bolivar R, Gomez LG, Luna M, Hopfer R, Bodey GP. Aspergillus epiglottitis. Cancer 1983;51:367–70
110. Waxman JE, Spector JG, Sale SR, Katzenstein AL. Allergic aspergillus sinusitis: concepts in diagnosis and treatment of a new clinical entity. Laryngoscope 1987;97:261–5
111. Katzenstein AL, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983;72:89–93
112. Stammberger H. Endoscopic surgery for mycotic and chronic recurring sinusitis. Ann Otol Rhinol Laryngol [Suppl] 1985;119:1–11
113. Beck-Mannagetta J, Necek D. Radiologic findings in aspergillosis of the maxillary sinus. Oral Surg Oral Med Oral Pathol 1986;62:345–9
114. Jahrsdoerfer RA, Ejercito VS, Johns M.M.E., Cantrell RW, Sydnor JB. Aspergillosis of the nose and paranasal sinuses. Am J Otolaryngol 1979;1:6–14
115. Gonty AA, Page LR. Aspergillosis of the maxillary sinus. Review of the literature and report of a case. Oral Surg 1977;43:350–6
116. Sekhar LN, Dujovny M, Rao GR. Carotid-cavernous sinus thrombosis caused by Aspergillus fumigatus. Case report. J Neurosurg 1980;52:120–5
117. Yu VL, Wagner GE, Shadomy S. Sino-orbital aspergillosis treated with combination antifungal therapy. Successful therapy after failure with amphotericin B and surgery. JAMA 1980;244:814–5
118. Miglets AW, Saunders WH, Ayers L. Aspergillosis of the sphenoid sinus. Arch Otolaryngol 1978;104:47–50
119. Lavelle WG. Aspergillosis of the sphenoid sinus. Ear Nose Throat J 1988;67:266–9
120. Larranaga J, Fandino J, Gomez-Bueno J, Rodriguez D, Gonzalez-Carrero J, Botana C. Aspergillosis of the sphenoid sinus simulating a pituitary tumor. Neuroradiology 1989;31:362–3
121. Fuchs HA, Evans RM, Gregg CR. Invasive aspergillosis of the sphenoid sinus manifested as a pituitary tumor. South Med J 1985;78:1365–7
122. Weber RS, Lopez-Berestein G. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B. Laryngoscope 1987;97:937–41
123. Romett JL, Newman RK. Aspergillosis of the nose and paranasal sinuses. Laryngoscope 1982;92:764–6
124. Smolansky SJ. Aspergillosis of the paranasal sinuses. Ear Nose Throat J 1978;57:320–3
125. Stevens MH. Aspergillosis of the frontal sinus. Arch Otolaryngol 1978;104:153–6
126. Weinstein M, Theron J, Newton TH. Aspergillosis involving the sphenoid sinus. Neuroradiology 1976;11:137–9
127. Scully RE, Gablabini JJ, McNeely BU, eds. Weekly clinicopathological exercises: case 36–1977. N Engl J Med 1977;297:546–51
128. Baydala LT, Yanofsky R, Akabutu J, Wenman WM. Aspergillosis of the nose and paranasal sinuses in immunocompromised children. Can Med Assoc J 1988;138:927–8
129. Swerdlow B, Deresinski S. Development of aspergillus sinusitis in a patient receiving amphothericin B. Tteatment with granulocyte transfusions. Am J Med 1984;76:162–6
130. Berkow RL, Weisman SJ, Provisor AJ, Weetman RM, Baehner RL. Invasive aspergillosis of paranasal tissues in children with malignancies. J Pediatr 1983;103:49–53
131. McGill TJ, Simpson G, Healy GB. Fulminant aspergillosis of the nose and paranasal sinuses: a new clinical entity. Laryngoscope 1980;90:748–54
132. Viollier A-F, Peterson DE, de Jongh CA, Newman KA, Gray WC, Sutherland JC, Moody MA, Schimpff SC. Aspergillus sinusitis in cancer patients. Cancer 1986;58:366–71
133. Doft BH, Clarkson JG, Rebell G, Forster RK. Endogenous Aspergillus endophthalmitis in drug abusers. Arch Ophthalmol 1980;98:859–62
134. Sihota R, Agarwal HC, Grover AK, Sood NN. Aspergillus endophthalmitis. Br J Ophthalmol 1987;71:611–3
135. Ho PC, Tolentino FI, Baker AS. Successful treatment of exogenous aspergillus endophthalmitis: a case report. Br J Ophthalmol 1984;68:412–5
136. Lance SE, Friberg TR, Kowalski RP. Aspergillusflavus endophthalmitis and retinitis in an intravenous drug abuser. A therapeutic success. Ophthalmology 1988;95:947–9
137. Roney P, Barr CC, Chun CH, Raff MJ. Endogenous aspergillus endophthalmitis. Rev Infect Dis 1986;8:955–8
138. Snip RC, Michels RG. Pars plana vitrectomy in the management of endogenous Candida endophthalmitis. Am J Ophthalmol 1976;82:699–704
139. Miller GR, Rebell G, Magoon RC, Kulvin SM, Forster RK. Intravitreal antimycotic therapy and the cure of mycotic endophthalmitis caused by a Paecilomyces lilacinus contaminated pseudophakos. Ophthalmic Surg 1978;9:54–63
140. Walsh JA, Haft DA, Miller MH, Loran MR, Friedman AH. Ocular penetration of 5-fluorocytosine. Invest Ophthalmol Vis Sci 1978;17:691–4
141. Caldwell DR, Kastl P, Ottman D. A fungal infection as an intrascleral abscess. Ann Ophthalmol 1981;13:841–2
142. Stenson S, Brookner A, Rosenthal S. Bilateral endogenous necrotizing scleritis due to Aspergillus oryzae. Ann Ophthalmol 1982;14:67–72
143. Rhine WD, Arvin AM, Stevenson DK. Neonatal aspergillosis. A case report and review of the literature. Clin Pediatr (Phila) 1986;25:400–3
144. Henze G, Aldenhoff P, Stephani U, Grosse G, Kazner E, Staib F. Successful treatment of pulmonary and cerebral aspergillosis in an immunosuppressed child. Eur J Pediatr 1982;138:263–5
145. Ramos-Gabatin A, Jordan RM. Primary pituitary aspergillosis responding to transsphenoidal surgery and combined therapy with amphotericin-B and 5-fluorocytosine. Case report. J Neurosurg 1981;54:839–41
146. Bradley SF, McGuire NM, Kauffman CA. Sino-orbital and cerebral aspergillosis: cure with medical therapy. Mykosen 1987;30:379–85
147. Goodman ML, Coffey RJ. Stereotactic drainage of Aspergillus brain abscess with long-term survival: case report and review. Neurosurgery 1989;24:96–9
148. Venugopal FV, Venugopal TV, Thiruneelakantan K, Subramanian S, Shetty B.M.V. Cerebral aspergillosis: report of two cases. Sabouraudia 1977;15:225–30
149. Klein HJ, Richter H-P, Schachenmayr W. Intracerebral aspergillus abscess: case report. Neurosurgery 1983; 13:306–9
150. Van de Wyngaert FA, Sindic C.J.M., Rousseau J J, Xavier F.G.F., Brucher JM, Laterre EC, Spinal arachnoiditis due to aspergillus meningitis in a previously healthy patient. J Neurol 1986;233:41–3
151. Gordon MA, Holzman RS, Senter H, Lapa EW, Kupersmith MJ. Aspergillus oryzae meningitis. JAMA 1976;235: 2122–3
152. Peacock JE Jr, McGinnis MR, Cohen MS. Persistent neutrophilic meningitis. Report of four cases and review of the literature. Medicine 1984;63:379–95
153. Ingwer I, McLeish KR, Tight RR, White AC. Aspergillus fumigatus epidural abscess in a renal transplant recipient. Arch Intern Med 1978;138:153–4
154. Mawk JR, Erickson DL, Chou SN, Seljeskog EL. Aspergillus infections of the lumbar disc spaces. Report of three cases. J Neurosurg 1983;58:270–4
155. Chee YC, Poh SC. Aspergillus epidural abscess in a patient with obstructive airway disease. Postgrad Med J 1983; 59:43–5
156. Cunningham M, Yu VL, TUrner J, Curtin H. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch Otolaryngol Head Neck Surg 1988;114:554–6
157. Stanley RJ, McCaffrey TV, Weiland LH. Fungal mastoiditis in the immunocompromised host. Arch Otolaryngol Head Neck Surg 1988;114:198–9
158. Petrak RM, Pottage JC Jr, Levin S, Invasive external otitis caused by Aspergillus fumigatus in an immunocompromised patient. J Infect Dis 1985;151:196
159. Perlmutter I, Perlmutter D, Hyams PJ. Fungal infection of the brain: an increasing threat. South Med J 1980;73:499–501
160. Green WR, Font RL, Zimmerman LE. Aspergillosis of the orbit. Report of ten cases and review of the literature. Arch Ophthalmol 1969;82:302–13
161. Milosev B, Mahgoub ES, Aal A, El Hassan AM. Primary aspergilloma of paranasal sinuses in the Sudan. A review of seventeen cases. Br J Surg 1969;56:132–7
162. Oates J, Clark DR, Chiodini P. Intracranial extension of paranasal sinus aspergillosis. J Laryngol Otol 1987; 101:188–90
163. Roselle GA, Baird IM. Aspergillus flavipes group osteomyelitis. Arch Intern Med 1979;139:590–2
164. Brown DL, Musher DM, Taffet GE. Hematogenously acquired Aspergillus vertebral osteomyelitis in seemingly immunocompetent drug addicts. West J Med 1987; 147:84–5
165. Tack KJ, Rhame FS, Brown B, Thompson RC Jr. Aspergillus osteomyelitis. Report of four cases and review of the literature. Am J Med 1982;73:295–300
166. Barnwell PA, Jelsma LF, Raff MJ. Aspergillus osteomyelitis. Report of a case and review of the literature. Diagn Microbiol Infect Dis 1985;3:515–9
167. McKee DF, Barr WM, Bryan CS, Lunceford EM Jr. Primary aspergillosis of the spine mimicking Pott’s paraplegia. J Bone Joint Surg [Am] 1984;66:1481–3
168. Nasca RJ, McElvein RB. Aspergillus fumigatus osteomyelitis of the thoracic spine treated by excision and interbody fusion. Spine 1985;10:848–50
169. De Buele K, De Doncker P, Cauwenbergh G, Koster M, Legendre R, Blatchford N, Daunas J, Chwetzoff E. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982–1987). Mycoses 1988;31:476–85
170. Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutman L, Buckley RH. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med 1981;71:59–66
171. Vandevelde AG, Mauceri AA, Johnson JE 3rd 5-Fluoro-cytosine in the treatment of mycotic infections. Ann Intern Med 1972;77:43–51
172. Morgenlander JC, Rossitch E, Rawlings CE. Aspergillus disc space infection: case report and review of the literature. Neurosurgery 1989;25:126–9
173. Holmes PF, Osterman DW, Tullos HS, Aspergillus discitis. Report of two cases and review of the literature. Clin Orthop 1988;226:240–6
174. Casscells SW. Aspergillus osteomyelitis of the tibia. A case report. J Bone Joint Surg [Am] 1978;60:994–5
175. Corrall CJ, Merz WG, Rekedal K, Hughes WT. Aspergillus osteomyelitis in an immunocompetent adolescent: a case report and review of the literature. Pediatrics 1982; 70:455–61
176. Corrado ML, Cleri D, Fikrig SM, Phillips JC. Aspergillosis in chronic granulomatous disease: therapeutic considerations. Am J Dis Child 1980;134:1092–4
177. Lazzarin A, Capsoni F. Disseminated aspergillosis. Am J Dis Child 1982;136:654
178. Bujak JS, Kwon-Chung KJ, Chusid MJ. Osteomyelitis and pneumonia in a boy with chronic granulomatous disease of childhood caused by a mutant strain of Aspergillus nidulans. Am J Clin Pathol 1974;61:361–7
179. Bickley LS, Betts RF, Parkins CW. Atypical invasive external otitis from aspergillus. Arch Otolaryngol Head Neck Surg 1988;114:1024–8
180. Cahill KM, El Mofty AM, Kawaguchi TP. Primary cutaneous aspergillosis. Arch Dermatol 1967;96:545–7
181. Caro I, Dogliotti M. Aspergillosis of the skin. Report of a case. Dermatologica 1973;146:244–8
182. Vedder JS, Schorr WF. Primary disseminated pulmonary aspergillosis with metastatic skin nodules. Successful treatment with inhalation. nystatin therapy. JAMA 1969; 209:1191–5
183. Gercovich FG, Richman SP, Rodriguez V, Luna M, McCredie KB, Bodey GP. Successful control of systemic Aspergillus niger infections in two patients with acute leukemia. Cancer 1975;36:2271–6
184. Elgefors B, Haugstvedt S, Brorsson JE, Esbjorner E. Disseminated aspergillosis treated with amphotericin B and surgery in a boy with chronic granulomatous disease. Infection 1980;8:174–6
185. Bruck HM, Nash G, Foley FD, Pruitt BA. Opportunistic fungal infection of the burn wound with Phycomycetes and Aspergillus-, a clinical-pathologic review. Arch Surg 1971;102:476–82
186. Kim SH, Mason AD, McManus WF, Okerberg CV, Pruitt BA. Burn wound mycosis and mortality [abstract]. Annual Scientific Assembly of Southern Medical Association 1988;81(Suppl 1):66
187. Stone HH, Cuzzell JZ, Kolb LD, Moskowitz MS, McGowan JE Jr. Aspergillus infection of the burn wound. J TVauma 1979;19:765–7
188. Salisbury RE, Silverstein P, Goodwin MN Jr. Upper extremity fungal invasions secondary to large burns. Plast Reconstr Surg 1974;54:654–9
189. Golladay ES, Baker SB. Invasive aspergillosis in children. J Pediatr Surg 1987;22:504–5
190. Kammer RB, Utz JP. Aspergillus species endocarditis. The new face of a not so rare disease. Am J Med 1974; 56:506–21
191. Swensson EE, Willman VL, Peterson GJ. Acute aortic occlusion from aspergillosis in a healthy patient with survival. J Vase Surg 1986;4:187–91
192. Caplan HI, Frisch E, Houghton JD, Climo MS, Natsios GA. Aspergillus fumigatus endocarditis. Report of a case diagnosed during life. Ann Intern Med 1968;68:378–85
193. Hairston P, Lee WH Jr. Management of infected prosthetic heart valves. Ann Thorac Surg 1970;9:229–37
194. Utley JR, Mills J, Roe BB. The role of valve replacement in the treatment of fungal endocarditis. J Thorac Cardiovasc Surg 1975;69:255–8
195. Cooper J.A.D., Weinbaum DL, Aldrich TK, Mandell GL. Invasive aspergillosis of the lung and pericardium in a nonimmunocompromised 33 year old man. Am J Med 1981;71:903–7
196. Mielke B, Weir B, Oldring D, von Westarp C. Fungal aneurysm: case report and review of the literature. Neurosurgery 1981;9:578–82
197. Brandt SJ, Thompson RL, Wenzel RP. Mycotic pseudoaneurysm of an aortic bypass graft and contiguous vertebral osteomyelitis due to Aspergillus fumigatus. Am J Med 1985;79:259–62
198. Flechner SM, McAninch JW. Aspergillosis of the urinary tract: ascending route of infection and evolving patterns of disease. J Urol 1981;125:598–601
199. Sakamoto S, Ogata J, Sakazaki Y, Ikegami K. Fungus ball formation of aspergillus in the bladder. An unusual case report. Eur Urol 1978;4:388–9
200. Salgia P, Mani MK. Renal aspergillosis-case report. Nephron 1985;40:376–8
201. Bibler MR, Gianis JT. Acute ureteral colic from an obstructing renal aspergilloma. Rev Infect Dis 1987;9:790–4
202. Khawand N, Jones G, Edson M. Aspergillosis of prostate. Urology 1989;34:100–1
203. Le CT, Dennis M. Adrenal mass in an immunocompromised man. Hosp Pract [Off] 1988;23:148–50.
204. Meyer RD, Young LS, Armstrong D, Yu B. Aspergillosis comlicating neoplastic disease. Am J Med 1973;54:6–15
205. Kravitz SP, Berry PL. Successful treatment of aspergillus peritonitis in a child undergoing continuous cycling peritoneal dialysis. Arch Intern Med 1986;146:2061–2
206. Rodriguez-TUdela JL, Barros C, Aguado JM, Gomez-Garces JL, Velo M, de Arriba G. Aspergillus niger peritonitis [letter], Nephrol Dial Transplant 1988;3:232
207. Mineur P, Ferrant A, Wallon J, Otte JB, Michaux JL. Bronchoesophageal fistula caused by pulmonary aspergillosis. Eur J Respir Dis 1985;66:360–6
208. Solary E, Rifle G, Chalopin JM, Rifle-Mediavilla C, Rebibou JM, Camerlynck P, Justrabo E, Cuisenier B, Caillot D, Mousson C, Tanter Y. Disseminated aspergillosis revealed by thyroiditis in a renal allograft recipient. Transplantation 1987;44:839–40
209. Halazun JF, Anast CS, Lukens JN. Thyrotoxicosis associated with Aspergillus thyroiditis in chronic granulomatous disease. J Pediatr 1972;80:106–8
210. Rao G.S.P., Mann S.B.S., Talwar P, Arora M.M.L., Primary mycotic infection of paranasal sinuses. Mycopathologia 1983;84:73–6
211. Ribner B, Keusch GT, Hanna BA, Perloff M. Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient. Chest 1976;70:681–3
212. Beyt BE Jr, Cannon RO 3rd, Tuteur PG, Successful treatment of invasive pulmonary aspergillosis in the immunocompromised host. South Med J 1978;71:1164–6
213. Sinclair AJ, Rossof AH, Coltman CA Jr. Recognition and successful management in pulmonary aspergillosis in leukemia. Cancer 1978;42:2019–24
214. Daenen S, Vellenga E, van Dobbenburgh OA, Halie MR. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia. Blood 1986;67:559–61
215. Mikulski SM, Love LJ, Bergquist EJ, Hargadon MT, Applefeld MM, Mergner W. Aspergillus vegetative endocarditis and complete heart block in a patient with acute leukemia. Chest 1979;76:473–6
216. Lutz P, Boulate P, Seiller F, Koenig H, Himy R, Sauvage P, Levy J-M, Aspergillose r£nale isolie chez un garfon leucemique. Pediatrie 1984;39:669–73
217. Wingard JR, Vaughan WP, Braine HG, Merz WG, Saral R. Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo- controlled trial of intravenous miconazole. Am J Med 1987;83:1103–10
218. Kyriakides GK, Zinneman HH, Hall WH, Arora VK, Lifton J, DeWolf WC, Miller J. Immunologic monitoring and aspergillosis in renal transplant patients. Am J Surg 1976;131:246–52
219. Modry DL, Stinson EB, Oyer PE, Jamieson SW, Baldwin JC, Shumway NE. Acute rejection and massive cyclospo- rine requirements in heart transplant recipients treated with rifampin. Transplantation 1985;39:313–4
220. Warshawsky AB, Keiller D, Gittes RF. Bilateral renal asper gillosis. J Urol 1975;113:8–11
221. Codish SJ, Tobias JS, Hannigan M. Combined amphotericin B-flucytosine therapy in aspergillus pneumonia. JAMA 1979;241:2418–9
222. Raubitschek AA, Levin AS, Stites DP, Shaw EB, Fudenberg HH. Normal granulocyte infusion therapy for aspergillosis in chronic granulomatous disease. Pediatrics 1973;51:230–3
223. Chudwin DS, Wara DW, Cowan MJ, Ammann AJ. Aspergillus pneumonia in chronic granulomatous disease: recurrence and long-term outcome. Acta Paediatr Scand 1982;71:915–7
224. Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982;61:109–24
225. Wagner DK, Werner PH, Bonchek LI, Shimshak T, Rytel MW. Successful treatment of post-mitral valve annuloplasty Aspergillus flavus endocarditis. Am J Med 1985;79:777–80
226. Drexler L, Rytel M, Keelan M, Bonchek LI, Olinger GN. Aspergillus terreus infective endocarditis on a porcine het- erogiaft valve. J Thorac Cardiovasc Surg 1980;79:269–74
227. Phillips P, Fetchick R, Weisman I, Foshee S, Graybill JR. Tolerance to and efficacy of itraconazole in treatment of systemic mycoses: preliminary results. Rev Infect Dis 1987;9(Suppl l):S87–93.
228. Ahmad M, Weinstein AJ, Hughes JA, Cosgrove DE. Granulomatous mediastinitis due to Aspergillus flavus in a nonimmunosuppressed patient. Am J Med 1981;70:887–90
229. Vieira DF, Van Saene H.K.F., Miranda DR. Invasive pulmonary aspergillosis after near-drowning. Intensive Care Med 1984;10:203–4
230. Spiteri MA, McCall J, Clarke SW. Successful management of primary invasive pulmonary aspergillosis. Br J Dis Chest 1986;80:297–301
231. Kerkering TM, Espinel-Ingroff A. In vitro synergistic activity of itraconazole and 5-fluorocytosine against Aspergillusfumigatus and Aspergillus flavus. In: Fromtling RA, ed. Recent trends in the discovery, development and evaluation of antifungal agents. Barcelona, Spain: J. R. Prous Science, 1987:61–70
232. Lopez-Berestein G. Liposomal-amphotericin B in the treatment of systemic mycoses in patients with cancer. In: Holmberg K, Meyer RD, eds. Diagnosis and therapy of systemic fungal infections. New York: Raven Press, 1989;159–66
233. Farquhar DL, Munro JF, Milne L.J.R., Piris J. Ketoconazole and fungal sinusitis. Scott Med J 1984;29:192–3
234. Boogaerts MA, Van de Pitte K, Verhoef G, Zachee P, de Beule K, Itraconazole prophylaxis of invasive fungal infection in prolonged neutropenia. In: Proceedings of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy [abstract no. 576]. Washington, DC: American Society for Microbiology, 1988
235. Stein AG, Daneshmend TK, Wamock DW, Bhaskar N, Burke J, Hawkey CJ. The effects of H2-receptor antagonists on the pharmacokinetics of itraconazole, a new oral antifungal. Br J Clin Pharmacol 1989;27:105–6P
236. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977;63:548–55
237. Winston DJ, Ho WG, Young LS, Gale RP. Prophylactic granulocyte transfusions during human bone marrow transplantation. Am J Med 1980;68:893–7
238. Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981;304:1185–9
239. Haber RH, Oddone EZ, Gurbel PA, Stead WW. Acute pulmonary decompensation due to amphotericin B in the absence of granulocyte transfusions. N Engl J Med 1986;315:836
240. Murray HW. Allergic reactions to amphotericin B. N Engl J Med 1974;290:693
241. Forman SJ, Robinson GV, Wolf JL, Spruce WE, Blume KG. Pulmonary reactions associated with amphotericin B and leukocyte transfusions. N Engl J Med 1981;305:584–5
242. DeGregorio MW, Lee WMF, Reis CA. Pulmonary reactions associated with amphotericin B and leukocyte transfusions. N Engl J Med 1981;305:585
243. Boxer LA, Ingraham LM, Allen J, Oseas RS, Baehner RL. Amphotericin-B promotes leukocyte aggregation of nylon- wool-fiber-treated polymorphonuclear leukocytes. Blood 1981;58:518–23
244. Berliner S, Weinberger M, Ben-Bassat M, Lavie G, Weinberger A, Giller S, Pinkhas J. Amphotericin B causes aggregation of neutrophils and enhances pulmonary leu- kostasis. Am Rev Respir Dis 1985;132:602–5
245. Savani DV, Perfect JR, Durack DT. Uptake of tritiated itraconazole by alveolar macrophages [abstract no. 1081]. In: Proceedings of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1987
246. Perfect JR, Granger DL, Durack DT. Effects of antifungal agents and γ interferon on macrophage cytotoxicity for fungi and tumor cells. J Infect Dis 1987;156:316–23
247. Denning DW, Stevens DA. New drugs for systemic fungal infections. Br Med J 1989;299:407–8
248. Burke PS, Coltman CA Jr. Multiple pulmonary aspergillomas in acute leukemia. Cancer 1971;28:1289–92
249. Auzanneau G, Schlaifer D, Carlioz R, Pemot P, Dupont B, Martoia R. Aspergillose pulmonaire invasive suivie d’une spondylodiscite L1-L2 au cours du traitement deduction d’une leucemie aigue lymphoblastique. Guerison par la triple association amphotericine B, 5-fluorocytosine, itraconazole et abord direct. Medecine et Maladies Infectieuses 1989;3:125–9
250. Pennington JE. Successful treatment of aspergillus pneumonia in hematologic neoplasia. N Engl J Med 1976;295:426–7
251. McGregor DH, Papasian C J, Pierce PD. Aspergilloma within cavitating pulmonary adenocarcinoma. Am J Clin Pathol 1989;91:100–3
252. Naidoff MA, Green WR. Endogenous Aspergillus endophthalmitis occurring after kidney transplant. Am J Ophthalmol 1975;79:502–9
253. Arnow PM, Andersen RL, Mainous PD, Smith EJ. Pulmonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978;118:49–53
254. Gurwith MJ, Stinson EB, Remington JS. Aspergillus infection complicating cardiac transplantation. Report of five cases. Arch Intern Med 1971;128:541–5
255. Chusid MJ, Sohnle PG, Fink JN, Shea ML. A genetic defect of granulocyte oxidative metabolism in a man with disseminated aspergillosis. J Lab Clin Med 1981;97:730–8
256. Chusid MJ, Gelfand JA, Nutter C, Fauci AS. Pulmonary aspergillosis, inhalation of contaminated marijuana smoke, chronic granulomatous disease [letter], Ann Intern Med 1975;82:682–3
257. Karam GH, Griffin FM Jr. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis 1986;8:357–63
258. Rodenhuis S, Beaumont F, Kauffman HF, Sluiter HJ. Invasive pulmonary aspergillosis in a non-immunosup-pressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin. Thorax 1984;39:78–9
259. Morton JR, Mihalas LS, Leung P, Strieder DJ. Corticosteroids and malnutrition. Aspergillus lung abscess in an asthmatic child. Chest 1980;78:667–9
260. McConnochie K, O, Sullivan M, Khalil JF, Pritchard MH, Gibbs AR, Aspergillus colonization of pulmonary rheumatoid nodule. Respiratory Medicine 1989;83:157–60
261. Schrijver G, Verwers HR, Meinders AE. A non-immuno-suppressed patient with presumably invasive pulmonary aspergillosis and a favourable outcome. Neth J Med 1983;26:112–9
262. Bach MC, Sahyoun A, Adler JL, Schlesinger RM, Breman J, Madras P, P’eng F-K, Monaco AP, Influence of rejection therapy on fungal and nocardial infections in renal- transplant recipients. Lancet 1973;1:180–4
263. Ledbetter EO, Ransom RW. Granulomatosis in infancy and childhood. Minn Med 1969;52:509–16
264. Manning LK, Robertson L. A case of aspergillosis treated with nystatin. Br Med J 1959;1:345–6
265. Zinneman HH. Sino-orbital aspergillosis. Report of a case and review of the literature. Minn Med 1972;55:661–4
266. Rothfeld L, Eliot G, Begg CF. Aspergilloma of sinus. NY State J Med 1972;72:493–5
267. McGinnis MR, Buck DL Jr, Katz B, Paranasal aspergilloma caused by an albino variant of Aspergillus fumigatus. South Med J 1977;70:886–8
268. Rossouw DP, Swart JG. Aspergillus fumigatus infection of the maxillary sinus. A case report. S Afr Med J 1988;73:47–8
269. Parnes LS, Brown DH, Garcia B. Mycotic sinusitis: a management protocol. J Otolaryngol 1989;18:176–80
270. Mitchell RG, Chaplin AJ, Mackenzie DW. Emericella nid-ulans in a maxillary sinus fungal mass. J Med Vet Mycol 1987;25:339–41
271. Axelsson H, Carlsoo B, Weibring J, Winblad B. Aspergillosis of the maxillary sinus. Clinical and histopathological features of 4 cases and a review of the literature. Acta Otolaryngol (Stockh) 1978;86:303–8
272. Friedman AH, Chishti MI, Henkind P. Endogenous ocular aspergillosis. Ophthalmologies 1974;168:197–205
273. Boldrey EE. Bilateral endogenous Aspergillus endophthalmitis. Retina 1981;1:171–4
274. Wilmarth SS, May DR, Roth AM, Cole R J, Nolan S, Goldstein E. Aspergillus endophthalmitis in an intravenous drug abuser. Ann Ophthalmol 1983;15:470–6
275. Meyer RD, Fox ML. Aspergillus endocarditis. Therapeutic failure of amphotericin B. Arch Intern Med 1973; 132:102–6
276. Hedges TR, Leung L-S, Parasellar and orbital apex syndrome caused by aspergillosis. Neurology 1976;26:117–20
277. Ferris B, Jones C. Paraplegia due to aspergillosis. Successful conservative treatment of two cases. J Bone Joint Surg [Am] 1985;67:800–3
278. Seres JL, Ono H, Benner EJ. Aspergillosis presenting as spinal cord compression. Case report. J Neurosurgery 1972;36:221–4
279. Wagner DK, Varkey B, Sheth NK, DaMert GJ. Epidural abscess, vertebral destruction, and paraplegia caused by extending infection from an aspergilloma. Am J Med 1985;78:518–22
280. Seligsohn R, Rippon JW, Lemer SA. Aspergillus terreus osteomyelitis. Arch Intern Med 1977;137:918–20
281. Attah CA, Cerruti MM. Aspergillus osteomyelitis of sternum after cardiac surgery. NY State J Med 1979;79:1420–1
282. Wellens F, Potvliege C, Deuvaert FE, Primo G. Aspergillus osteochondritis after median sternotomy. Combined operative treatment and drug therapy with amphotericin B. Thorac Cardiovasc Surg 1982;30:322–4
283. Simpson MB Jr, Merz WG, Kurlinski JP, Solomon MH. Opportunistic mycotic osteomyelitis: bone infections due to Aspergillus and Candida species. Medicine 1977; 56:475–82
284. Estes SA, Hendricks AA, Merz WG, Prystowsky SD. Primary cutaneous aspergillosis. J Am Acad Dermatol 1980;3:397–400
285. Myers JT, Dunn AD. Aspergillus infection of the hand. JAMA 1930;95:794–6
286. Rodriguez V, Bardwil JM, Bodey GP. Primary aspergilloma cured with amphotericin B. South Med J 1971;64:396–8
287. Goldberg B, Eversmann WW, Eitzen EM Jr. Invasive aspergillosis of the hand. J Hand Surg [Am] 1982;7:38–42
288. Carrizosa J, Levison ME, Lawrence T, Kaye D. Cure of Aspergillus ustus endocarditis on a prosthetic valve. Arch Intern Med 1974;133:486–90
289. Lang DM, Leisen J.C.C., Elliott JP, Lewis JW Jr, Wendt DJ, Quinn EL, Echocardiographically silent Aspergillus mural endocarditis. West J Med 1988;149:334–8
290. Opal SM, Reller LB, Harrington G, Cannady P Jr. Aspergillus clavatus endocarditis involving a normal aortic valve following coronary artery surgery. Rev Infect Dis 1986; 8:781–5
291. Vishniavsky N, Sagar KB, Markowitz SM. Aspergillus fumigatus endocarditis on a normal heart valve. South Med J 1983;76:506–8
292. Marchand R, Ahronheim GA, Patriquin H, Benoit P, Laberge I, de Repentigny L. Aspergilloma of the renal pelvis in a leukemic child. Pediatr Infect Dis J 1985;4:103–5
293. Hartmann BJ, Coleman M, Brause BD, Saletan S. Localized renal aspergillosis with hairy cell leukemia: a review of urinary tract aspergillosis in malignant and nonmalignant conditions. Cancer Invest 1984;2:199–202
294. Avisrror MU, Gomez JM, Abuin JS, Zancajo V.R.G. Solitary aspergillus mycetoma of the kidney. Eur Urol 1983;9:119–21
295. Comings DE, Hirbow BA, Callahan DH, Waldstein SS. Obstructing aspergillus cast of the renal pelvis. Report of a case in a patient having diabetes mellitus and Addison’s disease. Arch Intern Med 1962;110:255–61
296. Baird RW, Lancaster DJ. Diabetic ketoacidosis as the presentation of renal aspergilloma. Am J Med 1988;85:453–4
297. Myerson DA, Rosenfield AT. Renal aspergillosis: a report of two cases. Journal of the Association of Canadian Radiologists 1977;28:214–6
298. Chmel H, Grieco MH. Cerebral mucormycosis and renal aspergillosis in heroin addicts without endocarditis. Am J Med Sci 1973;266:225–31
299. Godec CJ, Mielnick A, Hilfer J. Primary renal aspergillosis. Urology 1989;34:152–4
300. Mende R, Sawicka A. Grzybica kropidlakowa nerki. Pol Tyg Lek 1964;19:308–10
301. Eisenberg RL, Hedgcock MW, Shanser JD. Aspergillus mycetoma of the renal pelvis associated with ureteropelvic junction obstruction. J Urol 1977;118:466–7